Bayer Statement on Essure Variance Letter from Food and Drug Administration (FDA) – April 24, 2020
(PDF 171.39 KB)
News Release: Bayer to voluntarily discontinue U.S. sales of Essure at end of 2018 for business reasons - July 20, 2018
(PDF 105.92 KB)
Washington Post: An Open Letter to Patients and Providers About Essure - July 27, 2018
(PDF 179.81 KB)
Essure: Frequently Asked Questions - July 29, 2018
(PDF 51.3 KB)